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ABSTRACT
Objectives: The purpose of this investigation was to
assess 30-day mortality among Danish inﬂammatory
bowel diseases (IBD) patients and to examine the
prognostic impact of hospital total colectomy volume,
age, gender and comorbidity.
Design: Cohort study.
Setting: The authors compared 30-day survival over
the period 1996e2010 among 2889 IBD patients with
total colectomy identiﬁed in the Danish National
Registry of Patients. This registry covers all hospitals
in Denmark. Postoperative survival patterns for
patients with ulcerative colitis and Crohn’s disease
were compared, using proportional hazard regression.
The regression model accounted for the timing of
surgery, hospital total colectomy volume, age, gender
and comorbidity.
Participants: Patients were enrolled in the study if
they had a hospital registry diagnosis of IBD, with
accompanying procedure codes for total colectomy
(see codes in online appendix table 1). Hospitalisations
were described as elective or emergency, and patients
were categorised as having Crohn’s disease, ulcerative
colitis or as a mixed group.
Outcome measures: Primary outcome measure was
30-day mortality.
Results: Among 2889 IBD patients with total
colectomy, 1439 (50%) underwent surgery during an
emergency hospitalisation. Thirty-day mortality was
5.3% (76/1439) among emergency cases compared
with 1% (14/1450) among elective cases. The highest
mortality (8.1%; 11 of 136) was observed among
Crohn’s patients undergoing emergency surgery. The
mortality of patients with ulcerative colitis undergoing
emergency surgery was 5.2% (55/1056). After elective
surgery, the 30-day mortality was 0.9% (8/938) among
patients with ulcerative colitis and 1.5% (3/201) among
Crohn’s disease patients. Low hospital total colectomy
volume, comorbidity and high age were associated
with increased 30-day mortality in ulcerative colitis
patients undergoing emergency surgery.
Conclusion: Emergency total colectomy
among patients with ulcerative colitis and particularly
Crohn’s disease is associated with substantial 30-day
mortality.
INTRODUCTION
Inﬂammatory bowel diseases (IBD) cause
serious morbidity and disability in people
of all ages. Medical treatment remains the
cornerstone for managing these diseases.
Over the past two decades, use of immuno-
suppressants such as azathioprine
1 2 has
increased signiﬁcantly as a treatment
modality. More recently, potent biological
treatments have proved effective in treating
To cite: Tøttrup A, Erichsen
R, Sværke C, et al. Thirty-day
mortality after elective and
emergency total colectomy in
Danish patients with
inﬂammatory bowel disease:
a population-based
nationwide cohort study.
BMJ Open 2012;2:e000823.
doi:10.1136/
bmjopen-2012-000823
< Prepublication history and
additional appendices for this
paper are available online. To
view these ﬁles please visit
the journal online (http://dx.
doi.org/10.1136/
bmjopen-2012-000823).
Received 10 January 2012
Accepted 2 March 2012
This ﬁnal article is available
for use under the terms of
the Creative Commons
Attribution Non-Commercial
2.0 Licence; see
http://bmjopen.bmj.com
1Department of Surgery P,
Aarhus University Hospital,
Aarhus C, Denmark
2Department of Clinical
Epidemiology, Aarhus
University Hospital, Aarhus
C, Denmark
Correspondence to
Dr Anders Tøttrup;
andtoe@rm.dk
ARTICLE SUMMARY
Article focus
- Elective and emergency total colectomy is
commonly performed in inﬂammatory bowel
disease.
- Emergency operations are associated with higher
mortality than elective procedures.
Key messages
- IBD patients undergoing emergency total colec-
tomy have a 30-day mortality of 5.3% as
opposed to 1% after elective total colectomy.
- Low hospital volume, high age and comorbidity
are associated with increased mortality in
patients with ulcerative colitis undergoing emer-
gency surgery.
- It is suggested to centralise treatment, and to
aim for elective procedures in high-risk patients.
Strengths and limitations of this study
- The study covers complete national data on total
colectomies performed for inﬂammatory disease.
- The unique ID number of all patients makes
recording of all events highly reliable.
- The main limitation is lack of access to speciﬁc
clinical parameters.
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Open Access Researchboth ulcerative colitis and Crohn’s disease.
3e7 Historical
data have shown that up to 83% of patients with Crohn’s
disease underwent at least one bowel resection during
a 10-year period
8 and up to 25% of patients with ulcer-
ative colitis needed surgical treatment.
9 While some
recent studies show that modern medical treatment may
decrease the need for surgery in IBD patients,
10e12
others suggest that this is not the case.
21 3
In patients with severe ulcerative colitis, colectomy
rates have remained stable over the past decades,
14
although the introduction of biological rescue therapy is
likely to decrease use of this surgical intervention in
coming years.
15 16 Mortality rates of up to 30% have been
reported historically in patients undergoing emergency
total colectomy for ulcerative colitis.
17 18 Delay in patient
referral for surgery has been proposed as the reason for
high postoperative mortality.
19 Although recent data
from a highly specialised centre showed inhospital
mortality of <1% after emergency colectomy,
20 popula-
tion-based studies from England
21 and the USA
22 have
reported postoperative mortality as high as 5.4%e5.7%
after emergency colectomy. This contrasts with rates as
low as 0.7%e0.8% after elective colectomy. Advanced
age, comorbidity, delay of more than 6 days between
hospital admission and colectomy and low hospital
volume have been associated with increased post-
operative mortality after colectomy in IBD patients.
22 23
In many countries, including Denmark, increasing
specialisation has occurred, with more rare and compli-
cated conditions treated at specialised centres. Still,
severe IBD continues to be treated at general district
hospitals, where the number of patients is low and
outcome appears to be poor.
24
The present study aimed to investigate 30-day
mortality after elective and emergency total colectomy in
Danish IBD patients, with special emphasis on the
prognostic impact of hospital total colectomy volume,
age, sex and comorbidity.
MATERIALS AND METHODS
We conducted this follow-up study in the setting of the
entire Danish population of 5.4 million people during
the period 1 January 1996 to 31 December 2010. The
Danish National Health Service provides tax-funded
medical care for all Danish residents.
Data sources
The Danish National Registry of Patients (DNRP)
contains data on all non-psychiatric hospitalisations in
Denmark since 1977 and on hospital outpatient clinic
contacts since 1995.
25 The DNRP records civil registra-
tion number, hospital code, department code, date and
type of admission (emergency/elective), dates and codes
of procedures, admission and discharge dates, selected
medical therapies and up to 20 discharge diagnoses,
coded by physicians according to the International
Classiﬁcation of Diseases (ICD), eighth revision until the
end of 1993 and 10th revision thereafter. It is mandatory
that all surgical procedures are coded according to the
Nordic Medico-Statistical Committee (NOMESCO)
classiﬁcation.
26
We linked individual-level data from the DNRP using
the civil registration number, a unique 10-digit identiﬁer
assigned at birth to all Danish residents by the Civil
Registration System.
27 The Civil Registration System also
tracks vital status and the residence of all Danish citizens
and is updated daily.
Patients with IBD and total colectomy
Patients were enrolled in the study if they had a hospital
registry diagnosis of IBD, with accompanying procedure
codes for total colectomy (see codes in online appendix
table 1). Hospitalisations were described as elective or
emergency, and patients were categorised as having
Crohn’s disease, ulcerative colitis or as a mixed group if
their records contained ICD codes for both Crohn’s
disease and ulcerative colitis. We also obtained infor-
mation on reoperation occurring within 30 days of the
primary surgery, tumour necrosis factor a inhibitor and
cyclosporine treatment in the year prior to surgery and
Clostridium difﬁcile infections (see codes in online
appendix table 1). We categorised IBD patients
according to age at date of total colectomy (0e39, 40e59
and 60+ years), year of colectomy (1996e2000,
2001e2005 and 2006e2010) and hospital total colec-
tomy volume deﬁned as annual number of total colec-
tomies performed on IBD patients by the surgical
department and categorised according to Kaplan et al
22
(low: <3, medium: 3e12 and high: 12+).
We also extracted information from the DNRP on
comorbidity, that is, diseases coexisting with IBD. We
summarised comorbidity status using the Charlson
Comorbidity Index (CCI).
28 The CCI’s scoring system
assigns between one and six points to a range of diseases.
Each patient’s sum of points represent a measure of his
or her comorbidity burden. We placed our study patients
into three groups according to their sum of points:
0 points (‘no comorbidity’), 1e2 points (‘low comor-
bidity’) and 3 or more points (‘high comorbidity’).
28 We
deﬁned comorbid diseases according to the ICD-10
codes provided by Quan et al
29, matching ICD-8 codes to
ICD-10 codes as closely as possible (see codes in online
appendix table 2).
Mortality data
We followed IBD patients who were acutely or electively
hospitalised for a procedure of total colectomy in the
period 1996e2010, from the date of colectomy until
death, 30 days postsurgery or 31 December 2010,
whichever came ﬁrst.
Statistical analysis
Our main outcome of interest was 30-day mortality,
estimated as the number of deaths after total elective or
emergency colectomy divided by the total number of
IBD patients undergoing elective/emergency colectomy.
We stratiﬁed our study sample by IBD type and by the
following covariates: gender, age at colectomy, year of
2 Tøttrup A, Erichsen R, Sværke C, et al. BMJ Open 2012;2:e000823. doi:10.1136/bmjopen-2012-000823
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22 duration
of hospitalisation prior to surgery (<8 days, $8 days),
presence or absence of tumour necrosis factor-a inhib-
itor or cyclosporine therapy in the year before the total
colectomy, reoperation, CCI score and colectomy
subtype. We calculated differences in mortality and
corresponding 95% CIs between patients undergoing
emergency versus elective surgery overall. We also
calculated mortality rates for ulcerative colitis patients by
age and hospital total colectomy volume. In addition, we
used Cox proportional-hazards regression to estimate
mortality rate ratios (MRR) for each covariate, using the
reference values shown in table 4. MRRs were adjusted
for age (0e39, $40 years), gender and CCI score (0 and
$1 points) to evaluate the independent prognostic
effect of the covariates included in the model. (We
lacked statistical power to mutually adjust for all cova-
riates.) In a subsequent analysis, we estimated the
proportion of patients who underwent reoperation, as
a secondary outcome.
RESULTS
Descriptive data
In total, 2889 IBD patients with total colectomy were
identiﬁed from the DNRP for the period 1 January
1996e31 December 2010. Of these, 1439 (49.8%)
underwent surgery during an emergency hospitalisation
(49% women). Characteristics of IBD patients by type of
surgery (elective and emergency) are shown in tables 1
and 2. The majority of patients had a total colectomy due
to ulcerative colitis (64.7% for elective cases; 73.4% for
emergency cases). Of the 1450 elective cases (51.9%
women), 718 (49.5%) were younger than 40 years, 438
(30.2%) were between ages 40 and 59 and the remaining
294 (20.3%) were $60 years old (table 1). Of the 1439
emergency cases, 693 (48.2%) were younger than
40 years, 390 (27.1%) were between ages 40 and 59 and
the remaining 356 (24.7%) were $60 years old (table 2).
The majority of elective (69.9%) and emergency
(65.1%) surgeries took place in high-volume hospitals
with >12 total colectomies/year (tables 1 and 2). None
Table 1 Characteristics of patients with an IBD diagnosis undergoing elective total colectomy in the period 1996e2010 in
Denmark
Ulcerative
colitis
Crohn’s
disease
Ulcerative colitis
and Crohn’s disease*
Total number (n¼1450) 938 (64.7%) 201 (13.9%) 311 (21.4%)
Males 485 (51.7%) 76 (37.8%) 137 (44.1%)
Females 453 (48.3%) 125 (62.2%) 174 (55.9%)
Age at operation
0e39 years 436 (46.5%) 121 (60.2%) 161 (51.8%)
40e59 years 292 (31.1%) 55 (27.4%) 91 (29.3%)
$60 years 210 (22.4%) 25 (12.4%) 59 (19.0%)
Number of annual colectomies for IBD performed in the surgical department
#3/year 131 (14.0%) 22 (11.0%) 45 (14.5%)
3e12/year 166 (17.7%) 28 (13.9%) 44 (14.1%)
>12/year 641 (68.3%) 151 (75.1%) 222 (71.4%)
Duration of hospitalisation before colectomy
Admitted <8 days before colectomy 557 (59.4%) 136 (67.7%) 178 (57.2%)
Admitted $8 days before colectomy 381 (40.6%) 65 (32.3%) 133 (42.8%)
Medical treatment within 1 year before colectomy
TNF-a and cyclosporine 64 (6.8%) 10 (5.0%) 37 (11.9%)
Reoperation within 30 days postoperatively 73 (7.8%) 21 (10.4%) 21 (6.8%)
Charlson Comorbidity Index Score
0 705 (75.2%) 146 (72.6%) 224 (72.0%)
1e2 194 (20.7%) 45 (22.4%) 69 (22.2%)
$3 39 (4.2%) 10 (5.0%) 18 (5.8%)
Colectomy type
Colectomy with ileorectal anastomosis (KJFH00e01) 54 (5.8%) 42 (20.9%) 39 (12.5%)
Colectomy with ileostomy (KJFH10e11) 523 (55.8%) 99 (49.3%) 170 (54.7%)
Proctocolectomy with ileostomy (KJFH20e21) 147 (15.7%) 49 (24.4%) 65 (20.9%)
Restorative proctocolectomy 6 ileostomy (KJFH30e33) 197 (21.0%) 5 (2.5%) 28 (9.0%)
Proctocolectomy with Koch reservoir (KJFH40) 1 (0.1%) 0 (0%) 0 (0%)
Other form of colectomy (KJFH96) 16 (1.7%) 6 (3.0%) 9 (2.9%)
Time period
1996e2000 307 (32.7%) 67 (33.3%) 114 (36.7%)
2001e2005 343 (36.6%) 78 (38.8%) 95 (30.6%)
2006e2010 288 (30.7%) 56 (27.9%) 102 (32.8%)
*Patients for whom codes for both ulcerative colitis and Crohn’s disease were used at any preceding or subsequent admission or hospital
contact.
IBD, inﬂammatory bowel disease; TNF, tumour necrosis factor.
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for infection with Clostridium difﬁcile.
Among all IBD patients, 1075 (74.1%) of elective cases
and 1097 (76.2%) of emergency cases had a CCI score of
0 and 375 (25.9%) of elective cases and 342 (23.8%) of
emergency cases had a score of 1 or higher. Comorbidity
scores were distributed almost equally between the three
IBD groups (tables 1 and 2). Total colectomy with
ileostomy was performed more often in emergency cases
than in elective cases (81.2% vs 54.6%). Proctocolectomy
with ileostomy was carried out in 102 emergency cases
(7.1%) and 261 elective cases (18%). Frequencies of
procedures by type and disease groups are shown in
tables 1 and 2.
Mortality
Within 30 days following colectomy, 14 of the 1450
patients who underwent elective surgery died (1.0%),
while 76 of the 1439 emergency patients (5.3%) died
(mortality difference ¼ 4.3%; 95% CI 3.1% to 5.6%).
Among ulcerative colitis patients, mortality was 0.9% (8/
938) in the elective group and 5.2% in the emergency
group. Patients with Crohn’s disease undergoing
emergency surgery had the highest 30-day mortality
(11/136¼8.1%).
Mortality was low in ulcerative colitis patients aged
under 40 years (0.2%, table 3), both for elective and
emergency surgery. For patients aged 60 years or older,
mortality increased to 3.3% for those undergoing
colectomy on an elective basis and to 18.4% for those
undergoing this procedure on an emergency basis
(mortality difference¼15.1%; 95% CI 9.8% to 20.3%).
Mortality was lowest in high-volume hospitals (0.5% for
elective and 3.6% for emergency cases (mortality differ-
ence¼3.1%; 95% CI 1.6% to 4.6%), table 3). Patients
with high CCI scores also had high mortality. Table 3
shows mortality according to duration of hospitalisation
prior to colectomy, colectomy type and time period.
Table 2 Characteristics of patients with an IBD diagnosis undergoing emergency total colectomy in the period 1996e2010 in
Denmark
Ulcerative
colitis
Crohn’s
disease
Ulcerative colitis
and Crohn’s disease*
Total number (n¼1439) 1056 (73.4%) 136 (9.5%) 247 (17.2%)
Males 559 (52.9%) 62 (45.6%) 113 (45.7%)
Females 497 (47.1%) 74 (54.4%) 134 (54.3%)
Age at operation
0e39 years 503 (47.6%) 56 (41.2%) 134 (54.3%)
40e59 years 286 (27.1%) 39 (28.7%) 65 (26.3%)
$60 years 267 (25.3%) 41 (30.1%) 48 (19.4%)
Number of annual colectomies for IBD performed in the surgical department
#3/year 168 (15.9%) 31 (22.8%) 43 (17.4%)
3e12/year 186 (17.6%) 24 (17.6%) 50 (20.2%)
>12/year 702 (66.5%) 81 (59.6%) 154 (62.4%)
Duration of hospitalisation before colectomy
Admitted <8 days before colectomy 296 (28.0%) 45 (33.1%) 85 (34.4%)
Admitted $8 days before colectomy 760 (72.0%) 91 (66.9%) 162 (65.6%)
Medical treatment within 1 year before colectomy
TNF-a and cyclosporine 67 (6.3%) 12 (8.8%) 23 (9.3%)
Reoperation within 30 days postoperatively 102 (9.7%) 11 (8.2%) 27 (10.9%)
Charlson Comorbidity Index Score
0 810 (76.7%) 96 (70.6%) 191 (77.3%)
1e2 194 (18.4%) 30 (22.1%) 49 (19.8%)
$3 52 (4.9%) 10 (7.3%) 7 (2.8%)
Colectomy type
Colectomy with ileorectal anastomosis (KJFH00d01) 38 (3.6%) 16 (11.8%) 19 (7.7%)
Colectomy with ileostomy (KJFH10d11) 875 (82.9%) 97 (71.3%) 196 (74.4%)
Proctocolectomy with ileostomy (KJFH20d21) 73 (6.9%) 8 (5.9%) 21 (8.5%)
Restorative proctocolectomy 6 ileostomy (KJFH30d33) 31 (2.9%) 2 (1.5%) 4 (1.6%)
Proctocolectomy with Koch reservoir (KJFH40) 1 (0.1%) 0 (0%) 0 (0%)
Other form of colectomy (KJFH96) 38 (3.6%) 13 (9.6%) 7 (2.8%)
Time period
1996e2000 371 (35.1%) 54 (39.7%) 90 (36.4%)
2001e2005 385 (36.5%) 36 (7.1%) 84 (34.0%)
2006e2010 300 (28.4%) 46 (11.0%) 73 (30.0%)
*Patients for whom codes for both ulcerative colitis and Crohn’s disease were used at any preceding or subsequent admission or hospital
contact.
IBD, inﬂammatory bowel disease; TNF, tumour necrosis factor.
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Mortality after total colectomy for inﬂammatory bowel diseaseNumbers of outcomes in patients with Crohn’s disease
or mixed Crohn’s disease/ulcerative colitis were too
small to permit more detailed analysis of mortality.
In a subsequent analysis, we found that reoperation
within 30 days occurred in 115 (7.9%) elective cases and
in 140 (9.7%) emergency cases and was associated with
particularly high mortality.
Prognostic factors in patients with ulcerative colitis
Crude and adjusted MRRs for patients with ulcerative
colitis are shown in table 4. Higher age at operation
($40 years) was associated with major increases in MRRs
in both emergency and elective cases. A CCI score $1
was associated with an increased MRR after emergency
colectomy but had no inﬂuence on MRR in patients
undergoing elective colectomy. MRRs were lower for
cases undergoing surgery at high-volume hospitals
compared with low-volume hospitals. In the regression
model for emergency colectomies, gender, duration of
hospitalisation before colectomy and time period were
not clearly associated with mortality. In the regression
model for elective colectomies, hospitalisation for 8 days
or more prior to surgery was associated with an increased
MRR. Numbers were too low to permit calculation of
MRRs for patients with Crohn’s disease or with both
ulcerative colitis and Crohn’s disease.
DISCUSSION
Our study showed that 30-day postoperative mortality
after total colectomy was 5.3% for IBD patients under-
going surgery on an emergency basis and 1% for those
with elective procedures. We also found that comor-
bidity, surgery in a hospital performing few annual
colectomies and age over 40 were associated with
increased mortality after emergency total colectomy in
patients with ulcerative colitis. Age over 40 and hospi-
talisation for 8 days or more prior to colectomy were
associated with increased mortality in ulcerative colitis
patients undergoing elective total colectomy.
Our data extend previous research with recent popu-
lation-based data. Mortality after emergency total colec-
tomy for ulcerative colitis was as high as 27%
19 30e32 in
the past. More recent data from tertiary referral centres
indicate inhospital mortality of <0.6%.
20 33 34 However,
a short report on a small number of patients treated at
a district general hospital in the UK raised concerns that
mortality remains considerably higher than estimates
based on tertiary centres.
24 This was conﬁrmed in
a record linkage study conducted in England for the
period 1998e2000 by Roberts et al. In that study, 30-day
mortality was 0.8% following elective colectomy and
5.7% following emergency colectomy in ulcerative colitis
patients.
21 A later study by Kaplan et al
22, based on the
American Nationwide Inpatient Sample database,
reported similar ﬁgures of 0.7% and 5.4% for inhospital
mortality following elective and emergency colectomy,
respectively, in ulcerative colitis patients. This large-scale
American study, covering approximately 20% of
Veterans’ Administration admissions, identiﬁed low
hospital volume for colectomies, age over 40, comor-
bidity and hospitalisation for more than 7 days prior to
colectomy as independent prognostic factors. Our study
supports these previous population-based investigations,
showing that 30-day postoperative mortality after total
colectomy is probably not as low as suggested by reports
from tertiary referral centres. In addition, both the
Table 4 Mortality rate ratios in patients with ulcerative colitis undergoing total colectomy in the period 1996e2010 in Denmark
Emergency Elective
Crude Adjacent Crude Adjacent
Females Ref. Ref. Ref. Ref.
Males 1.15 (0.68e1.97) 1.16 (0.68e1.98) 0.94 (0.23e3.74) 0.79 (0.20e3.19)
Age at operation
0e39 years Ref Ref Ref Ref
$40 years 26.18 (11.2e61.1) 17.78 (7.3e43.1) 24.65 (3.0e200) 24.51 (2.81e213.8)
Number of annual colectomies for IBD performed by the surgical department
#3/year Ref. Ref. Ref. Ref.
3e12/year 0.51 (0.24e1.06) 0.58 (0.28e1.23) 1.18 (0.20e7.08) 1.51 (0.25e9.18)
>12/year 0.30 (0.17e0.55) 0.46 (0.25e0.84) 0.30 (0.05e1.82) 0.63 (0.10e3.89)
Duration of hospitalisation before colectomy
Admitted <8 days before colectomy Ref. Ref. Ref. Ref.
Admitted $8 days before colectomy 0.62 (0.36e1.06) 0.67 (0.39e1.16) 10.30 (1.27e83.6) 10.26 (1.25e84.2)
Charlson comorbidity index score
0 Ref. Ref. Ref. Ref.
$1 7.20 (4.10e12.65) 2.56 (1.42e4.61) 3.05 (0.76e12.2) 1.06 (0.25e4.46)
Time period
1996e2000 Ref. Ref. Ref. Ref.
2001e2005 0.87 (0.48e1.60) 0.90 (0.49e1.64) 0.90 (0.06e14.31) 0.90 (0.06e14.54)
2005e2010 0.72 (0.36e1.43) 0.60 (0.30e1.20) 6.47 (0.78e53.7) 5.18 (0.62e43.6)
Adj, adjusted for age, gender and comorbidity.
IBD, inﬂammatory bowel disease.
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Mortality after total colectomy for inﬂammatory bowel diseaseAmerican study and our study underscore that a high
volume of these surgeriesdand consequently a high
degree of experiencedmay be important in reducing
postoperative mortality after both emergency and
elective total colectomy in IBD patients.
35
Our ﬁnding of 8.1% 30-day mortality after emergency
surgery in Crohn’s disease patients contrasts with the
Roberts et al
21 study, which found a 30-day mortality of
only 2.9%. The main reason for this difference may be
that we included only patients with total colectomy,
while Roberts et al included patients undergoing all
types of colectomy, including right hemicolectomy.
Regrettably, the number of patients in the Crohn group
was low precluding detailed statistical analysis of this
cohort of patients. The group of patients with both
a diagnosis of ulcerative colitis and Crohn’s disease was
relatively large, and we assume that it includes patients,
whose diagnosis has indeed been reclassiﬁed. It may also
include patients, who at a single occasion has received an
incorrect diagnosis because we expanded our search for
diagnosis to a period beginning in 1997 and continuing
until conclusion of the study. In this respect, our
study was different to the previous population-based
studies.
21e23
The high mortality observed in our study calls for
a critical revision of indications for elective and emer-
gency colectomy in patients with Crohn’s colitis. A key
recommendation is to treat patients with severe ulcera-
tive colitis in highly specialised centres. Similar recom-
mendations could be made for patients with Crohn’s
disease, although the number of patients included in the
present study was too low to provide statistical support.
Our study also conﬁrmed that older age, emergency
procedures and a high degree of comorbidity are
associated with increased mortality after intestinal
surgery.
22 23 36 37 In addition, it is known from popula-
tion-based studies that hospitalisation for ulcerative
colitis has a two-peak age incidence in a number of
countries including Denmark.
38 We found that a high
proportion of patients with ulcerative colitis underwent
total colectomy after age 60. An elective procedure
performed earlier in life would most likely reduce
mortality in these patients. Interestingly, comorbidity
had no inﬂuence on MRRs among patients undergoing
elective surgery. This suggests that interventions to
address comorbidities such as elevated blood pressure,
arrhythmias and diabetes may have taken place preop-
eratively, ensuring a safer postoperative course. It is not
possible from the present result to speculate about the
inﬂuence of surgical procedure on mortality. First of all,
the number of patients in the different subgroups is
fairly low precluding statistical subgroup analysis, and
second, the preoperative condition of the patients has
probably had inﬂuence on the choice of surgical
procedure.
When medical treatment cannot achieve remission,
delaying surgery can increase morbidity and mortality.
19 39
Thus, Kaplan et al
22 reported more than a doubling of
the MRR among patients who were hospitalised (and
presumably treated medically) for more than 7 days
prior to surgery. Our study conﬁrmed these ﬁndings for
the subgroup undergoing elective surgery.
The main strength of the present study is its nation-
wide population-based design in the setting of a free tax-
supported healthcare system with complete information
on follow-up. Moreover, we used a validated approach to
identify IBD patients undergoing surgery.
40 These
features ensure generalisability of our results and mini-
mise selection bias. In addition, we were able to adjust
for a number of important covariates, including comor-
bidity, for which we had high-quality data.
41
Our study also had several limitations. Although we
used a validated approach to identify colectomized IBD
patients, approximately 16% had codes corresponding
to both Crohn’s disease and ulcerative colitis. As
mentioned, this is most likely due to some degree of
coding error. We therefore grouped IBD patients with
mixed codes separately to minimise misclassiﬁcation of
the Crohn’s and ulcerative colitis groups. We also did
not have access to important clinical parameters, such as
reasons for deciding to proceed with surgery or to
discontinue medical treatment. Thus, we were unable to
investigate the role of these important issues in relation
to postoperative mortality. Finally, registration of rescue
therapy with cyclosporine or inﬂiximab was probably
incomplete because such registration has only recently
become compulsory in our country.
In conclusion, we observed high 30-day mortality
among IBD patients undergoing emergency total colec-
tomy. Among patients with ulcerative colitis, 30-day
mortality was 5.2% after total emergency colectomy, and
among patients with Crohn’s disease, it was 8.1%. Low
hospital volume of colectomy, comorbidity and age over
40 were important prognostic factors.
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